Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer

Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-related apoptosis-indu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Kim, Jung Lim, Kim, Bo Ram, Kim, Dae Yeong, Jeong, Yoon A., Jeong, Soyeon, Na, Yoo Jin, Park, Seong Hye, Yun, Hye Kyeong, Jo, Min Jee, Kim, Bu Gyeom, Kim, Han Do, Kim, Dae Hyun, Oh, Sang Cheul, Lee, Sun Il, Lee, Dae-Hee
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562873/
https://ncbi.nlm.nih.gov/pubmed/31075907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050642
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky